Published in Br J Psychiatry on October 01, 2011
How to teach psychiatry to medical undergraduates in India?: a model. Indian J Psychol Med (2013) 1.34
The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry (2012) 1.32
Psychiatry in 21(st) century: The road ahead. J Neurosci Rural Pract (2014) 1.11
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ (2012) 5.26
Eating disorders. Lancet (2003) 5.26
Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry (2006) 3.24
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry (2003) 3.18
Engagement of patients with psychosis in the consultation: conversation analytic study. BMJ (2002) 3.00
Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci U S A (2006) 2.71
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. J Clin Psychiatry (2015) 2.67
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
What British psychiatrists read: questionnaire survey of journal usage among clinicians. Br J Psychiatry (2004) 2.29
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ (2013) 2.28
Photosynthetic architecture differs in coastal and oceanic diatoms. Nature (2004) 2.22
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ (2012) 2.17
Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry (2004) 2.11
A meta-analysis of depression severity and cognitive function. J Affect Disord (2009) 1.94
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2005) 1.88
Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication. Pharmacopsychiatry (2004) 1.82
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol (2008) 1.80
Role of GABA in anxiety and depression. Depress Anxiety (2007) 1.79
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A (2012) 1.79
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry (2006) 1.78
Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry (2005) 1.76
Race and mental health: there is more to race than racism. BMJ (2006) 1.70
Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res (2004) 1.66
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2010) 1.63
The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62
Acute tryptophan depletion. Part II: clinical effects and implications. Aust N Z J Psychiatry (2005) 1.62
GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev (2012) 1.61
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59
CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord (2013) 1.56
A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry (2009) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
A tale of two Es. J Psychopharmacol (2006) 1.53
Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia. Cereb Cortex (2002) 1.53
Assertive outreach teams in London: patient characteristics and outcomes. Pan-London Assertive Outreach Study, part 3. Br J Psychiatry (2003) 1.52
Threats and offers in community mental healthcare. J Med Ethics (2011) 1.51
A systematic review of the effect of community treatment orders on service use. Soc Psychiatry Psychiatr Epidemiol (2013) 1.51
The decline and fate of an iron-induced subarctic phytoplankton bloom. Nature (2004) 1.50
Status of bipolar disorder research. Bibliometric study. Br J Psychiatry (2003) 1.49
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry (2006) 1.48
Antidepressants and their effect on sleep. Hum Psychopharmacol (2005) 1.48
Substitution therapy for alcoholism: time for a reappraisal? J Psychopharmacol (2011) 1.47
Social exclusion and mental health: conceptual and methodological review. Br J Psychiatry (2007) 1.47
Predictors of employment for people with severe mental illness: results of an international six-centre randomised controlled trial. Br J Psychiatry (2008) 1.43
Illness careers and continuity of care in mental health services: a qualitative study of service users and carers. Soc Sci Med (2009) 1.43
MDMA, politics and medical research: have we thrown the baby out with the bathwater? J Psychopharmacol (2007) 1.42
Transcranial stimulation in depression. Br J Psychiatry (2012) 1.42
Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry (2009) 1.41
Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem (2007) 1.41
Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology (2013) 1.40
Dopamine and social anxiety disorder. Rev Bras Psiquiatr (2006) 1.38
Prescribing antidepressants post Cipriani et al. J Psychopharmacol (2009) 1.37
Human taste thresholds are modulated by serotonin and noradrenaline. J Neurosci (2006) 1.36
Neuronal density, size and shape in the human anterior cingulate cortex: a comparison of Nissl and NeuN staining. Brain Res Bull (2004) 1.36
Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol (2003) 1.36
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.36
Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry (2009) 1.31
Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association? Biol Psychiatry (2011) 1.29
d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci (2007) 1.29
A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry (2013) 1.28
Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. Brain (2012) 1.27
Prevalence of violent victimisation in severe mental illness. Br J Psychiatry (2003) 1.25
Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med (2006) 1.25
Specialty choice in UK junior doctors: is psychiatry the least popular specialty for UK and international medical graduates? BMC Med Educ (2009) 1.25
Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry (2004) 1.24
Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci (2003) 1.23
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.22
Amphetamine, past and present--a pharmacological and clinical perspective. J Psychopharmacol (2013) 1.22
The effects of APOE on the functional architecture of the resting brain. Neuroimage (2011) 1.22
The cognitive neuropsychology of depression in the elderly. Psychol Med (2007) 1.22
Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage (2006) 1.20
Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry (2009) 1.20
Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry (2011) 1.18
White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage (2007) 1.18
Assertive outreach teams in London: models of operation. Pan-London Assertive Outreach Study, part 1. Br J Psychiatry (2003) 1.18
Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse (2004) 1.17
Characteristics of teams, staff and patients: associations with outcomes of patients in assertive outreach. Br J Psychiatry (2004) 1.17
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab (2010) 1.16
COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Biol Psychiatry (2012) 1.16
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology (2010) 1.16
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study. Synapse (2007) 1.15
Schizophrenia: a genetic disorder of the synapse? BMJ (2005) 1.14
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Res (2003) 1.13
Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage (2012) 1.13
The future of academic psychiatry may be social. Br J Psychiatry (2013) 1.12
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia. Curr Med Res Opin (2009) 1.12
Balancing the benefits and risks of public-private partnerships to address the global double burden of malnutrition. Public Health Nutr (2011) 1.12
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy. Proc Natl Acad Sci U S A (2012) 1.12
Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry (2005) 1.11
The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT (2008) 1.11
Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"? Neuroimage (2003) 1.10
5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev (2011) 1.10
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl) (2007) 1.10
Assisted outpatient treatment services and the influence of compulsory treatment. Am J Psychiatry (2014) 1.09
Cape Town consensus on posttraumatic stress disorder. CNS Spectr (2009) 1.09
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers. Depress Anxiety (2005) 1.09